Maze Therapeutics (MAZE) Current Assets (2024 - 2026)

Maze Therapeutics has disclosed Current Assets across 3 years of filings, most recently posting $379.8 million for Q1 2026.

• Current Assets for Q1 2026 came in at $379.8 million, up 26.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $379.8 million (up 26.72% YoY), and the FY2025 annual result was $349.7 million, up 73.41% from the prior year.
• Current Assets came in at $379.8 million for Q1 2026 at Maze Therapeutics, up from $349.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $391.3 million in Q3 2025 to a low of $201.7 million in Q4 2024.
• The 3-year median for Current Assets is $324.7 million (2025), against an average of $315.6 million.
• Across the five-year window, Current Assets soared 73.41% in 2025 and rose 26.72% in 2026, its largest moves.
• Maze Therapeutics' Current Assets stood at $201.7 million in 2024, then jumped by 73.41% to $349.7 million in 2025, then grew by 8.6% to $379.8 million in 2026.
• The last three Current Assets figures came in at $379.8 million (Q1 2026), $349.7 million (Q4 2025), and $391.3 million (Q3 2025), per Business Quant data.